PR97690

MILAN, Sept. 6, 2022 /PRNewswire=KYODO JBN/ --

"Human Brains" is the result of an in-depth research process undertaken by

Fondazione Prada in 2018 in the field of neuroscience. The project has featured

an online conference dedicated to the study of consciousness, a series of video

talks by international scientists, philosophers and researchers, and an

exhibition on the history of brain studies, currently on view in Venice until

27 November 2022.

The fourth phase of "Human Brains, titled "Preserving the Brain – Forum on

Neurodegenerative Diseases", will comprise an exhibition (16 September – 10

October 2022) and a conference (6 and 7 October 2022) at Fondazione Prada's

Milan premises.

"Preserving the Brain" aims to stimulate an open and critical exchange between

international scientists and experts on neurodegenerative diseases, such as

Alzheimer's, Parkinson's, Amyotrophic lateral sclerosis and Multiple sclerosis,

which are widely spread and as yet incurable.

As stated by Miuccia Prada, President of Fondazione Prada, "For us, this phase

of the project is particularly significant as it permits a closer understanding

of scientific research's impact on our everyday lives, and in particular on the

discovery of possible cures and treatments. 'Preserving the Brain' also

demonstrates how critical collaboration and sharing of knowledge are within the

scientific community. This first international forum could become recurring and

allow the organizations we are associated with to communicate with a wider

audience, as they would like to, and Fondazione Prada to contribute tangibly to

neuroscientific research."

The pivotal moment of "Preserving the Brain" will be the scientific conference

held on 6 and 7 October 2022, at Fondazione Prada's Cinema in Milan. The

speakers will explore the subject of neurodegenerative diseases from different

perspectives, such as genetic implications and molecular mechanisms, clinical

trials and possible drug treatments. The conference is addressed to researchers

and universities involved in the project and representatives of prominent

institutions in the health sector. The sessions will also be streamed and

visible to all on the online platform: humanbrains.fondazioneprada.org.

The exhibition will be held from 16 September to 10 October 2022 in the Podium,

the space at the center of Fondazione Prada's Milan venue. Conceived by the New

York studio 2x4, the exhibition design will be divided into different sections

supervised by the research centers, and a common central area that will

encourage dialogue and exchanges between the thirteen institutes. Each section

will examine a specific research process on neurodegenerative diseases

employing video presentations, technological objects and instruments,

scientific documents, and visual materials.

Throughout the opening of the exhibition, the 13 institutions participating in

the project will give a series of online workshops that will be available to

the public at humanbrains.fondazioneprada.org. Each meeting will enable the

assessment of a specific aspect in the search for new treatments for

neurodegenerative diseases.

"Preserving the Brain" is realized in collaboration with thirteen of the most

prestigious international neuroscience institutes and universities: Harvard

Medical School, Brigham and Women's Hospital, Ann Romney Center for

Neurological Diseases, Boston, United States; Hôpital de la Pitié-Salpêtrière,

Sorbonne University AP-HP, Neurology department and Paris Brain Institute,

Paris, France; UniSR – Università Vita-Salute San Raffaele, Milan, Italy;

Juntendo University Hospital, Neurology Department, Tokyo, Japan; Karolinska

Institutet, Stockholm, Sweden; German Center for Neurodegenerative Diseases

(DZNE) within the Helmholtz Association, Bonn, Germany; Max Planck Institute of

Neurobiology, Munich, Germany; Montreal Neurological Institute-Hospital, McGill

Research and Teaching Institute, Canada; Tianjin Medical University General

Hospital, Neurology Department, Tianjin, China; UCSF Weill Institute for

Neurosciences, University of California San Francisco, San Francisco, United

States; University College London, United Kingdom; Weizmann Institute of

Science, Revohot, Israel; Yale School of Medicine, New Haven, United States.

Media Contact:

FONDAZIONE PRADA – PRESS OFFICE

PRESS@FONDAZIONEPRADA.ORG

+39 02 56 66 26 34

Photo:

https://mma.prnewswire.com/media/1885561/Fondazione_Prada_Human_Brains.jpg

Logo: https://mma.prnewswire.com/media/1631439/Fondazione_Prada_Logo.jpg

SOURCE: Fondazione Prada